Literature DB >> 22832383

Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.

Lin-Qiang Li1, Xue-Lian Li, Lu Wang, Wei-Jie Du, Rui Guo, Hai-Hai Liang, Xue Liu, De-Sen Liang, Yan-Jie Lu, Hong-Li Shan, Hong-Chi Jiang.   

Abstract

BACKGROUND: Matrine is one of the major alkaloids extracted from Sophora flavescens and has been used clinically for breast cancer with notable therapeutic efficacy in China. However, the mechanisms are still largely unknown.
METHODS: Cell viability was analyzed by MTT assay. After MCF-7 cells were treated with matrine for 48h, apoptosis was detected by flow cytometry, TUNEL assay and transmission electron microscopy, and the cell cycle distribution was also analyzed by flow cytometry. Further, the expression of PTEN, pAkt, Akt, pBad, Bad, p21(/WAF1/CIP1), and p27(/KIP1) was determined by Western blot. Changes of miR-21 level were quantified by real-time RT-PCR. After miR-21 was transfected in MCF-7 cells, PTEN protein level was measured by Western blot.
RESULTS: Matrine inhibited MCF-7 cell growth in a concentration-and time-dependent manner, by inducing apoptosis and cell cycle arrest at G(1)/S phase. Matrine up-regulated PTEN by downregulating miR-21 which in turn dephosphorylated Akt, resulting in accumulation of Bad, p21(/WAF1/CIP1) and p27(/KIP1).
CONCLUSION: Our study unraveled, for the first time, the ability of matrine to suppress breast cancer growth and elucidated the miR-21/PTEN/Akt pathway as a signaling mechanism for the anti-cancer action of matrine. Our findings also reinforce the notion that miRNAs can act as mediators of the therapeutic efficacy of natural medicines.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832383     DOI: 10.1159/000341444

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  48 in total

1.  The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.

Authors:  M Fragni; S A Bonini; P Bettinsoli; S Bodei; D Generali; A Bottini; P F Spano; M Memo; S Sigala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-24       Impact factor: 3.000

2.  Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway.

Authors:  Shujun Zhang; Binglin Cheng; Hali Li; Wei Xu; Bo Zhai; Shangha Pan; Lei Wang; Ming Liu; Xueying Sun
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

3.  Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.

Authors:  Hui Guo; Yuemin Xu; Qiang Fu
Journal:  Tumour Biol       Date:  2015-06-02

4.  A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.

Authors:  Ying Liu; Yang Qi; Zhi-Hui Bai; Chen-Xu Ni; Qi-Hui Ren; Wei-Heng Xu; Jing Xu; Hong-Gang Hu; Lei Qiu; Jian-Zhong Li; Zhi-Gao He; Jun-Ping Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-10-24       Impact factor: 6.150

5.  Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells.

Authors:  Aslı Tetik Vardarlı; Zekeriya Düzgün; Ceren Erdem; Burçin Tezcanli Kaymaz; Zuhal Eroglu; Vildan Bozok Çetintas
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

6.  Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines.

Authors:  Zohreh Jahanafrooz; Nasrin Motamed; Behnaz Bakhshandeh
Journal:  Cytotechnology       Date:  2017-03-20       Impact factor: 2.058

Review 7.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

8.  miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.

Authors:  Dan-Dan Wang; Su-Jin Yang; Xiu Chen; Hong-Yu Shen; Long-Ji Luo; Xiao-Hui Zhang; Shan-Liang Zhong; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-04

9.  Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway.

Authors:  Tingting Bi; Ao Zhu; Xufeng Yang; Huiying Qiao; Jinmei Tang; Yan Liu; Rong Lv
Journal:  Cytotechnology       Date:  2017-11-06       Impact factor: 2.058

10.  NFI-A disrupts myeloid cell differentiation and maturation in septic mice.

Authors:  Clara McClure; Ekram Ali; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  J Leukoc Biol       Date:  2015-08-10       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.